What is Nektar Therapeutics's EV / sales?

Nektar Therapeutics (NKTR) reported EV / sales of 38.5× in Q1 2026.

How has Nektar Therapeutics's EV / sales changed year-over-year?

Nektar Therapeutics's EV / sales increased by 1428.3% year-over-year, from 2.5× to 38.5×.

What is the long-term trend for Nektar Therapeutics's EV / sales?

Over 5 years (2020 to 2025), Nektar Therapeutics's EV / sales has grown at a -4.5% compound annual growth rate (CAGR), from 21.5× to 17.1×.

What does EV / sales mean?

Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.

Nektar Therapeutics NKTR EV / sales

EV / sales at other companies

AmgenAMGN

6.6×+0.1×

Regeneron PharmaceuticalsREGN

5.5×+0.6×

ImmunityBio, Inc.IBRX

57.9×-33.2×

ImmunomeIMNM

472×+442×

Iovance Biotherapeutics, Inc.IOVA

4.5×0.0×

IncyteINCY

2.9×+0.6×

Other financials

Income statement

See full

Revenue$10.9M+3.8%

Gross profit$21.8M+2.9%

Operating income-$39.1M+12.3%

Net income-$44.9M+11.7%

EPS (diluted)-$1.82+49.7%

Balance sheet

See full

Cash & equivalents$5.7M-20.0%

Total debt$83.2M-17.1%

Total equity$576.2M+4,094%

Total assets$763.3M+198%

Cash flow

See full

Operating cash flow-$44.3M+9.7%

CapEx$18.0K+800%

Free cash flow-$44.3M+9.7%

Valuation

See full

Market cap$2.25B+1,531%

Enterprise value$2.33B+874%

P/S40.5×+38.9×

Profitability

See full

Gross margin100%+31.2pp

Operating margin-242%—

Net margin-284.2%+937pp

FCF margin-366.6%+1,421pp

Returns & leverage

See full

Return on equity-53.6%-22.6pp

Debt / equity0.1×-7.2×

Current ratio10.2×+7.0×

Where this comes from

Calculated from Nektar Therapeutics’s reported figures.

enterprise value/total revenue=38.5×

Based on the most recent quarter.

The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nektar Therapeutics's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nektar Therapeutics's EV / sales?: Nektar Therapeutics (NKTR) reported EV / sales of 38.5× in Q1 2026.
How has Nektar Therapeutics's EV / sales changed year-over-year?: Nektar Therapeutics's EV / sales increased by 1428.3% year-over-year, from 2.5× to 38.5×.
What is the long-term trend for Nektar Therapeutics's EV / sales?: Over 5 years (2020 to 2025), Nektar Therapeutics's EV / sales has grown at a -4.5% compound annual growth rate (CAGR), from 21.5× to 17.1×.
What does EV / sales mean?: Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.